ANRO Alto Neuroscience, Inc.
Fundamentals / CIK 0001999480 / USDAlto Neuroscience, Inc. reported $326.5M in total assets and a net loss of $95.18M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ANRO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$100.5M Operating profit
-
Net Income FY 2025-$95.18M GAAP bottom line
-
Diluted EPS FY 2025-$2.05 Split-adjusted
-
Free Cash Flow FY 2025-$79.68M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$319.3M Total debt: $15.52M
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Research & Development | $45.62M | $47.00M | $30.29M |
| Total Operating Expenses | $66.36M | $68.61M | $37.81M |
| Operating Income | -$66.36M | -$68.61M | -$37.81M |
| EBITDA | -$65.70M | -$68.11M | -$37.44M |
| Interest Income | $6.60M | $8.85M | $2.35M |
| Interest Expense | $2.47M | $1.38M | $1.37M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income | -$63.24M | -$61.43M | -$36.30M |
| Basic EPS | -$2.19 | -$2.50 | -$9.73 |
| Diluted EPS | -$2.19 | -$2.50 | -$9.73 |
| Basic Shares Outstanding | 28.9M | 24.6M | 3.7M |
| Diluted Shares Outstanding | 28.9M | 24.6M | 3.7M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $18.16M | $22.11M | $20.29M | $12.00M | $10.53M | $13.12M | $9.97M | $10.80M |
| Total Operating Expenses | $27.23M | $29.13M | $27.14M | $17.05M | $14.95M | $18.68M | $15.68M | $17.00M |
| Operating Income | -$27.23M | -$29.13M | -$27.14M | -$17.05M | -$14.95M | -$18.68M | -$15.68M | -$17.00M |
| EBITDA | -$27.12M | -$28.93M | -$26.95M | -$16.90M | -$14.75M | -$18.58M | -$15.51M | -$16.83M |
| Interest Income | $2.60M | $2.11M | $1.56M | $1.56M | $1.53M | $1.68M | $1.83M | $2.13M |
| Interest Expense | $463K | $491K | $545K | $575K | $650K | $646K | $598K | $333K |
| Income Tax Expense | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$25.12M | -$27.64M | -$26.24M | -$16.18M | -$14.18M | -$17.71M | -$15.17M | -$15.20M |
| Basic EPS | -$0.54 | -$0.65 | -$0.80 | -- | -$0.52 | -$0.65 | -$0.56 | -- |
| Diluted EPS | -$0.54 | -$0.65 | -$0.80 | -- | -$0.52 | -$0.65 | -$0.56 | -- |
| Basic Shares Outstanding | 46.5M | 42.8M | 32.9M | -- | 27.1M | 27.1M | 27.0M | -- |
| Diluted Shares Outstanding | 46.5M | 42.8M | 32.9M | -- | 27.1M | 27.1M | 27.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $176.5M | $168.2M | $82.55M |
| Cash & Short-Term Investments | $176.5M | $168.2M | $82.55M |
| Other Current Assets | -- | $30K | $112K |
| Total Current Assets | $177.7M | $169.3M | $85.39M |
| Property, Plant & Equipment, Net | $1.87M | $2.67M | $1.11M |
| Total Non-Current Assets | $6.97M | $8.21M | $1.24M |
| Total Assets | $184.7M | $177.5M | $86.63M |
| Accounts Payable | $1.88M | $1.58M | $1.07M |
| Short-Term Debt | $585K | $0 | $0 |
| Total Current Liabilities | $11.32M | $10.01M | $5.61M |
| Long-Term Debt | $16.17M | $10.25M | $9.86M |
| Total Non-Current Liabilities | $22.22M | $16.07M | $11.21M |
| Total Liabilities | $33.55M | $26.08M | $16.82M |
| Total Debt (incl. Leases) | $21.73M | $15.64M | $9.99M |
| Retained Earnings | -$201.6M | -$138.4M | -$76.97M |
| Accumulated Other Comp. Income | $22K | -$101K | -$79K |
| Total Stockholders' Equity | $151.1M | $151.5M | -$71.67M |
| Total Equity | $151.1M | $151.5M | -$71.67M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $319.3M | $243.7M | $263.8M | $176.5M | $137.8M | $147.6M | $160.8M | $168.2M |
| Cash & Short-Term Investments | $319.3M | $243.7M | $263.8M | $176.5M | $137.8M | $147.6M | $160.8M | $168.2M |
| Other Current Assets | -- | -- | -- | -- | -- | -- | $23K | $30K |
| Total Current Assets | $323.2M | $247.3M | $269.1M | $177.7M | $139.4M | $149.8M | $163.5M | $169.3M |
| Property, Plant & Equipment, Net | $1.87M | $2.05M | $2.23M | $1.87M | $2.03M | $2.31M | $2.48M | $2.67M |
| Total Non-Current Assets | $3.31M | $6.75M | $7.13M | $6.97M | $7.56M | $8.03M | $8.39M | $8.21M |
| Total Assets | $326.5M | $254.1M | $276.3M | $184.7M | $147.0M | $157.9M | $171.9M | $177.5M |
| Accounts Payable | $3.47M | $4.02M | $3.37M | $1.88M | $2.06M | $1.67M | $1.38M | $1.58M |
| Short-Term Debt | $4.51M | $3.77M | $2.14M | $585K | -- | -- | -- | $0 |
| Total Current Liabilities | $17.84M | $16.65M | $13.12M | $11.32M | $9.04M | $8.13M | $7.26M | $10.01M |
| Long-Term Debt | $8.97M | $12.42M | $13.88M | $16.17M | $20.31M | $20.12M | $19.94M | $10.25M |
| Total Non-Current Liabilities | $12.14M | $18.16M | $19.77M | $22.22M | $26.40M | $26.34M | $25.56M | $16.07M |
| Total Liabilities | $29.98M | $34.82M | $32.89M | $33.55M | $35.45M | $34.47M | $32.82M | $26.08M |
| Total Debt (incl. Leases) | $15.52M | $20.83M | $20.88M | $21.73M | $25.40M | $25.31M | $25.23M | $15.64M |
| Retained Earnings | -$280.6M | -$255.5M | -$227.9M | -$201.6M | -$185.5M | -$171.3M | -$153.6M | -$138.4M |
| Accumulated Other Comp. Income | $19K | $17K | $13K | $22K | $14K | $31K | $14K | -$101K |
| Total Stockholders' Equity | $296.5M | $219.2M | $243.4M | $151.1M | $111.6M | $123.4M | $139.1M | $151.5M |
| Total Equity | $296.5M | $219.2M | $243.4M | $151.1M | $111.6M | $123.4M | $139.1M | $151.5M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$63.24M | -$61.43M | -$36.30M |
| Depreciation & Amortization | $661K | $502K | $373K |
| Stock-Based Compensation | $8.11M | $7.63M | $2.89M |
| Change in Payables | $221K | $516K | -$632K |
| Operating Cash Flow | -$51.77M | -$47.42M | -$33.45M |
| Capital Expenditure | -$24K | -$2.08M | -$470K |
| Free Cash Flow | -$51.79M | -$49.50M | -$33.92M |
| Investing Cash Flow | -$24K | -$2.08M | -$470K |
| Financing Cash Flow | $60.08M | $135.7M | $68.13M |
| Net Change in Cash | $8.26M | $86.18M | $34.20M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$25.12M | -$27.64M | -$26.24M | -$16.18M | -$14.18M | -$17.71M | -$15.17M | -$15.20M |
| Depreciation & Amortization | $100K | $200K | $184K | $157K | $200K | $100K | $171K | $170K |
| Stock-Based Compensation | $3.52M | $3.55M | $2.82M | $1.95M | $2.19M | $2.00M | $1.97M | $1.57M |
| Change in Payables | -$544K | $652K | $1.49M | -$297K | $461K | $323K | -$266K | -$762K |
| Operating Cash Flow | -$20.76M | -$19.76M | -$27.09M | -$11.52M | -$9.92M | -$13.78M | -$16.56M | -$13.02M |
| Capital Expenditure | $0 | $0 | -$556K | $0 | $0 | $0 | -$24K | -$506K |
| Free Cash Flow | -$20.76M | -$19.76M | -$27.65M | -$11.52M | -$9.92M | -$13.78M | -$16.58M | -$13.53M |
| Investing Cash Flow | $0 | $0 | -$556K | $0 | $0 | $0 | -$24K | -$506K |
| Financing Cash Flow | $96.36M | -$273K | $114.9M | $50.19M | $153K | $613K | $9.13M | $49K |
| Net Change in Cash | $75.61M | -$20.03M | $87.28M | $38.67M | -$9.77M | -$13.17M | -$7.47M | -$13.47M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Return on Equity (ROE) | -41.8% | -40.6% | -- |
| Return on Assets (ROA) | -34.2% | -34.6% | -41.9% |
| Current Ratio | 15.69x | 16.92x | 15.22x |
| Quick Ratio | 15.58x | 16.81x | 14.71x |
| Debt to Equity | 0.14x | 0.10x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -32.1% | -38.4% | -30.5% | -41.8% | -55.8% | -52.6% | -45.4% | -40.6% |
| Return on Assets (ROA) | -29.2% | -33.2% | -26.9% | -34.2% | -42.3% | -41.1% | -36.8% | -34.6% |
| Current Ratio | 18.12x | 14.85x | 20.52x | 15.69x | 15.42x | 18.43x | 22.53x | 16.92x |
| Quick Ratio | 17.90x | 14.64x | 20.11x | 15.58x | 15.24x | 18.16x | 22.15x | 16.81x |
| Debt to Equity | 0.05x | 0.10x | 0.09x | 0.14x | 0.23x | 0.21x | 0.18x | 0.10x |